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Abstract
Brain development follows a complex process orchestrated by diverse molecular
and cellular events for which a perturbation can cause pathologies. In fact, multiple
neuronal cell fate decisions driven by complex gene regulatory programs are
involved in neurogenesis and neurodevelopment, and their characterization are
part of the current challenges on neurobiology. In this chapter, we provide an
overview of the various genomic strategies in use to explore the spatiotemporally
defined gene regulatory wires implicated in brain development. Finally, we will
discuss the intake of these approaches for understanding the multifactorial events
implicated in neurodevelopment and the future requirements for further expanding
our understanding of the brain.
Keywords: neurogenesis, gene regulatory networks, cell fate, systems biology,
functional genomics
1. Introduction
Since the release of the first draft of the human genome and the development of
massive parallel DNA sequencing strategies, our understanding of the genetic basis
for a variety of human illnesses, including neurological disease, has expanded rap-
idly. In fact, around 50% of the known Mendelian disorders were already matched
with their underlined genes [1] and this gap is expected to further decrease, namely
by the improvements in the analysis of non-coding genomic regions [2]. This being
said, the performance on the identification of the genetic context of diseases with
complex phenotypes is more modest, probably due to their multigenic etiology. In
fact, the use of exome sequencing for the detection of new mutations in an
unknown gene in family pedigrees appeared as a straight approach in the context of
Mendelian disorders, but at most it provides the list of common variants when
applied to neurological illnesses with complex phenotypes. As a consequence, fur-
ther functional genomic readouts, including transcriptomes, transcription factors
profiling, or epigenetic landscaping, are required to further narrow the observed
mutations and to reconstitute the complex relationship among the various genes
implicated on the inset of the disease.
In this context, this chapter will focus on the use of such further readouts to
complement previous exome sequencing efforts (for a review on the use of exome
sequencing applied to neurological diseases: [3]) and provide an overview of the
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integrative computational strategies in use. Importantly, the concept of gene net-
works as an approach to describe the inter-relationship among the various impli-
cated genes on the disease is discussed and illustrated by the major efforts
performed over the last years in the field of neurodevelopment and related diseases
(Figure 1). Finally, we discuss the arrival of new technological approaches for
enhancing our capacity to interrogate the human nervous tissue, which in contrary
to other tissues, remained till recently restricted to postmortem collected samples.
2. Interrogating neurodevelopment events by functional genomics
The evolution of genomics analyses, notably due to the sequencing of the human
genome, allowed to study neurodevelopment from a different perspective; i.e., by
the interrogation of the role of the genetic context during neurodevelopment. In
fact, while the implication of genes in this process was previously studied at the
individual level with the use of in-situ hybridization and RT-PCR methods, the
developments in DNA microarray and RNA-sequencing technologies provided a
global perspective as witnessed by the various studies focused on the brain
transcriptome either from the whole organ or particular regions and across stages of
development. Among them, the work, performed by Kang et al., for the establish-
ment of transcriptomes from 57 postmortem human brains in 16 regions across the
lifespan spanning developmental embryos through adulthood corresponds to one of
the earliest most comprehensive studies. In fact, beyond the large amounts of data,
they provided a spatiotemporal transcriptome regulation view enhanced by the
establishment of gene co-expression networks recapitulating different stages of
development. Importantly, this study highlighted that the majority of spatiotempo-
ral differences happen before the birth with a shift of gene expression patterns
around the birth in the neocortex. Principally in the fetal brain, genes with a role in
cell proliferation, cell migration, and neuronal differentiation are expressed in con-
trast to the late fetal period and infancy, where genes coding to dendrite and
synapse development are found [4].
Further studies performed by Colantuoni et al. focused on the temporal dynamic
of the transcriptome in prefrontal cortex in a large number of human brain samples
demonstrated that genes expressed differently in prenatal brain fetal development
are reversed during postnatal life [5] with the recruitment of new genes in the early
developmental brain [6]. With the same idea, the pattern of spatial gene expression
in brain was shown to follow a way determined by embryonic origin that can
change during development [7]. In fact, Pletikos et al. defined three phases in
neocortical development: the prenatal with highest differential gene expression, the
preadolescent phase with increasing synchronization of areal transcriptome, and
Figure 1.
Timeline recapitulating major achievements in understanding of healthy or disease-affected human brain
development by the use of functional genomics approaches.
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the adolescence where differential expressions among area reappear [8]. The spatial
part of transcriptome analysis gave the proof of structure gene regulation in human
brain. Especially, differences in gene expression profiling were demonstrated
between brain substructures or sites with the presence of region-specific genes
[9–11]. Hawrylycz et al. combined histological analysis with microarray in 900
neuroanatomic subdivisions from two human brains and observed that the spatial
topography of the neocortex is reflected in its transcriptomic topography where
closer cortical regions have similar gene expression [12]. However, symmetry bilat-
erally between two hemispheres was observed during development [8, 9, 11]. In
addition, the gene expression variability exists also between layers of neocortex.
The neocortex consists of six horizontal layers with subsets of neurons, the tran-
scriptional analysis of the layers in prefrontal cortex showed human specific layer
gene expression patterns [13]. A study realized by Miller et al. demonstrated dif-
ferential gene expression between proliferative and postmitotic layers in mid gesta-
tion human fetal brain with the presence of a molecular gradient frontotemporal in
cortical layers [14]. These observations supported the gene expression gradients
along the anteroposterior axis of neocortex [15].
While informative, the transcriptome analysis over the whole brain or
performed on specific regions is issued from the analysis of multiple cells possibly
presenting heterogeneous cell types populations. The development in single-cell
transcriptomics appears as a relevant alternative for gathering information about
cell types. The single-cell whole transcriptomic analysis permitted to identify cellu-
lar heterogeneity in the brain and subtypes of neuronal cells with differential gene
expression between fetal and adult neurons [16]. Single nuclear transcriptome in
the adult cerebral cortex was used to see diversity in neuronal subtypes and neuro-
anatomical areas [17]. Habib et al. combined this technique of single nucleus
RNA-Seq with pulse-labeling proliferative cells using the thymidine analog, the
5-ethynyl-20-deoxyuridine (EdU), to identify hippocampal cellular types and track
transcriptional trajectories single proliferating cells in the adult hippocampal neu-
rogenic niche [18]. Similarly, a recent single-cell RNA-Seq study in the human fetal
cortex and medial ganglionic eminence during prenatal neurogenesis demonstrated
the presence of lineage specific trajectories dependent of transcription regulatory
[19]. This study also demonstrated the modest transcriptional differences in cortical
radial glia cascade which conducts robust typological differences in neurons. In the
same context, Lake et al. combined single-cell sequencing with epigenome readouts
in adult human brain cells to reveal chromatin/transcription factor regulatory
events within distinct cell types [20]. Recently, Fan et al. also performed single-cell
spatial transcriptome analysis in human brain mid gestation embryos, where they
observed heterogeneity in each cortex region with no synchronization in cortex
development and maturation [21].
The study of the transcriptional expression behavior during brain development
is expected to enhance our understanding of pathological situations. Autism spec-
trum disorder (ASD), a heterogeneous pathology with prevalence of 1 in 59 chil-
dren, is one of these examples. The pathogenesis of ASD is characterized by social
impairments, disrupted communication skills and repetitive behaviors. Numerous
genes were shown to be implicated in ASD and their gene co-expression and/or
gene regulatory networks analyses are providing new insights on the impaired/
affected pathways on this disorder. In fact, several studies have tried to identify
transcriptome alterations implicated in ASD using either DNA microarray hybridi-
zation assays or genome sequencing. By comparing autistic and control brain sam-
ples, upregulated genes implicated in immune function, while others repressed and
involved in neurodevelopment or synaptogenesis were highlighted [22–24].
Another study described a dysregulation in mitochondrial oxidative
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phosphorylation and protein translation pathways without seeing changes in DNA
methylation [25]. Consistent with this observation, the downregulation of genes
involved in mitochondrial and synaptic function were also reported by using mul-
tiple genomics datasets like RNA-Seq and microarray studies previously published
[26]. Interestingly, dysfunction in synaptic pathways was also described in another
neurodevelopmental disease, namely schizophrenia [27–30]. This pathology affect-
ing approximately 1% of the population is characterized by personality distur-
bances, hallucinations, delusions, and/or disorganizing behavior. High-throughput
transcriptomic analysis revealed multiple deregulated genes in schizophrenia
[29–32]. Several of them are implicated in neurodevelopmental pathways, neuronal
communication, energy metabolism, and synaptic function [29, 30, 32]. Changes
in DNA methylation related to the prenatal-postnatal life transition were also
reported by comparing schizophrenia postmortem and unaffected control brain
samples, strongly arguing for the implication of an epigenetic regulation in the
disease’s development [33–35].
In addition to the observed changes in gene expression, alternative RNA splicing
has been described to occur at high frequency in human brain samples,
corresponding to more than one-third of the human brain transcriptome [9, 36]. In
addition, beyond the reported changes in protein coding gene expression [37], non-
coding micro RNAs (miRNA) and/or long non-coding RNAs (lncRNA) were shown
to have a role in neurodevelopment, participating in the reinforcement of brain
complexity. Indeed, Ziats et al. described differential miRNAs expression in differ-
ent parts of human brain along time of development with a principal shift that
happens after the birth [38]. In the same idea, changes in lncRNA transcriptome
during brain development [39], preferentially across fetal development with spatial
regulation, were described [40]. LncRNAs also play a role in neuronal differentia-
tion and neurogenesis, as suggested by studies highlighting a differential expression
of lncRNAs during differentiation from human pluripotent stem cells [41, 42]. One
example is the lncRNA rhabdomyosarcoma 2-associated transcript (RMST) which
through its interaction with SOX2 regulates downstream genes implicated in
neurogenesis [43]. The dysregulation of miRNA or lncRNA expression was also
observed in autism [44–46], schizophrenia [47], and intellectual disability [48]. In
this last case, lncRNAs were shown to be implicated in synaptic transmission,
neurogenesis, or neurodevelopment.
Across these different transcriptome studies, a variety of databases hosting
microarray and/or RNA-Seq data are currently available (for a comprehensive
review, see [49]). Among them, we can cite the HB Atlas [4, 9], the BrainSpan
Consortium [14], Brain Cloud [5], the Allen Brain map portal [12], the cortex single
cells [19], or the single-cell portal [18]. In addition, several consortia, sometimes
covering topics beyond the brain tissue, are at the basis of the establishment of
major databases. Among others, we can cite the “Genotype Tissue Expression
(GTex)” regrouping gene expression data issued from different tissues covering
more than 600 donors [50]. Similarly, the “Encyclopedia of DNA Elements
(ENCODE)” regroups large-scale datasets from various projects and combines
multi-omics data from different species, variety of cell lines and tissues at different
stages of development. A more specialized version of ENCODE, the “Psychiatric
Encyclopedia of DNA Elements (PsychENCODE),” collects datasets concerning
epigenetic modifications and non-coding RNA in healthy and disease-related
human brains [51]. In the context of the data issued from brain samples, Huisman
et al. developed the web portal “Brainscope” providing an interactive visualization
of Allen Atlas adult brain transcriptome and across different stages of development
[52]. Recently, a method to predict mRNA expression in whole brain using micro-
array data from Allen Brain Atlas with in-vivo positron emission tomography (PET)
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data was developed [53]. Overall, the generation of these databases correspond to
major efforts for the research community, providing centralized access to the large
collections of data; thus, further efforts of data integration can be performed, for
instance by the reconstruction of gene regulatory networks on the basis of previ-
ously generated transcriptomes.
3. Inferring molecular coregulatory events from the integration of
collected functional genomic readouts
The development of mid/high throughput strategies for analyzing genome
sequences, their variants, gene expression, or even the proteome composition,
provided means to the scientific community to interrogate each of these layers of
complexity in a variety of model systems and tissues and in addition to integrate
them to reconstruct a regulatory view. As illustrated in the previous section, several
studies described major functional genomic readouts focused on studying brain
development in normal and disease settings.
While being comprehensive, in most cases they provide relevant list of players
(gene variants, differentially expressed genes, etc.) on the basis of statistical
descriptors but forgets completely to address their potential relationship. Or, from a
biological point of view, each of the players composing the system under study is
expected to directly (or indirectly) influence the behavior of others. As a conse-
quence, the current challenge is to evolve into an integrative view, focused on
studying the various “deregulated events” as interconnected entities by the incor-
poration of multiple types of readouts and supported by computational solutions.
From an historical perspective, the article of Walsh et al. released in Science in
2008, corresponds to one of the first major studies aiming at identifying
neurodevelopmental programs involved in a disease context like schizophrenia
[54]. In this study, the authors hypothesized that the collective contribution of each
of the rare structural variants retrieved on neurological/neurodevelopmental syn-
dromes accounts for these disorders, and in the specific case of schizophrenia, they
have demonstrated a difference of at least 3-fold between controls and individuals
with schizophrenia on the frequency of rare structural variants within coding
regions. Furthermore, they have focused on structural mutations that disrupt genes,
and evaluated their functions with the help of computational solutions querying for
gene enrichment in one or more functionally defined pathways (PANTHER and
Ingenuity Pathway Analysis). This strategy per se aims at establishing gene rela-
tionships on the basis of their annotation to a given program (or pathway), even
though in this case such relationships are inferred in-silico.
Since then, further studies incorporated other types of data, like the use of RNA-
Seq transcriptomic analysis to identify the differentially expressed genes between
controls and individuals with schizophrenia, which are then associated to biological
functions by Gene ontology analysis [55–57]. Furthermore, the development of
computational solutions for enhancing data integration has being performed like in
the case of NETBAG, which allows to integrate multiple types of genetic variations
like single nucleotide variants (SNVs), rare copy number variants (CNVs), and
genome-wide association studies (GWAS), to identify highly connected gene clus-
ters, potentially related to functional roles. NETBAG was initially described in the
context of de novo CNVs in autism [58] and schizophrenia [59].
Beyond correlating changes in gene expression with the identification of genetic
variations, further efforts are required for stratifying information, like the use of
gene co-expression strategies. This approach aims at aggregating genes on the
grounds of their expression levels under the hypothesis that co-expressed genes are
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the consequence of a common regulatory force; e.g., the action of transcription
factors. This analysis can be represented under a network structure, on which a pair
of genes is displayed interconnected on the basis of their significant co-expression
relationship. This strategy has been applied by Voineagu and colleagues to resolve
consistent differences in transcriptomes assessed over autistic and normal brain
samples [23]. Specifically, they have resolved gene expression levels in cortical
regions (suggesting cortical abnormalities in the context of autism), but in addition
they have managed to identify discrete modules of co-expressed genes, clearly
demonstrating the advantages of such strategy for enhancing the analytical resolu-
tion. Since then, various studies incorporated gene co-expression analysis together
with genome-wide association data (GWAS) [60, 61], incorporated multiple human
brain regions and issued from various human development stages as a way to
identify specific biological processes and defined brain regions associated to autism
disorder [62, 63].
While gene co-expression networks are expected to be the consequence of the
action of defined master transcription factors, their identity remains unknown in
this type of analysis. The combination of chromatin immunoprecipitation (ChIP)
with massive parallel sequencing provided means to scrutinize the genome locations
on which given TFs are located. Furthermore, on the basis of their proximity to
annotated coding regions, it is possible to infer their transcriptional regulation
activity over proximal genes. Following such strategy, factors like TBR1 [64] or
Auts2 [65, 66], initially identified by rare genetic variant studies were ChIP-
sequenced to reveal their direct targets. In both cases, they were found located on
genomic regions adjacent to autism spectrum disorder (ASD)-related genes. A
similar strategy has been applied to map the gene targets associated to the chroma-
tin modifier CHD8 (chromodomain helicase) [67], previously shown to be mutated
in rare genetic variant studies [68].
Although powerful for the identification of the target genes for a given factor,
performing ChIP-Seq assays remains still challenging for covering a large number of
TFs, epigenetic modifications, and/or chromatin remodelers which could appear
associated to neurodevelopmental events. In fact, identifying strategies to prioritize
the list of TFs to be immunoprecipitated remains a key step, which is currently
handled by applying computational strategies. In this context, we have recently
developed TETRAMER, a computational approach able to reconstruct gene regula-
tory networks from the integration of transcriptomes provided by the user and
annotations retrieved in various databases concerning TF-Target gene relationships
[69]. Furthermore, TETRAMER simulates transcription regulation propagation
over the reconstructed connectivity to identify master TFs, which could then be
prioritized for experimental assays. This strategy has been initially used for identi-
fying novel master TFs implicated on neurogenesis by reconstructing gene regula-
tory networks from temporal transcriptomes [70]; then, it has been extrapolated to
a collection of more than 3000 transcriptomes covering 300 cell/tissue types and
representing 14 different anatomical systems in the human body. Among them, 58
cell/tissue types composing the human nervous system were analyzed, for which
their relevant master TFs as well as their related gene regulatory networks were
inferred. As illustrated in Figure 2, this type of analysis allows to compare the
fraction of shared TFs retrieved on different nervous systems, thus providing
to highlight relevant players implicated on their transcriptional regulation. In
Figure 2, a comparison between the TFs retrieved on frontal cortex and hypothal-
amus is depicted, revealing the presence of factors like TBR1 or ARNT2, previously
identified as presenting rare genetic variants associated to autism disorders [64, 71]
or NPAS3, previously described as a master regulator of neuropsychiatric related
genes [72].
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Overall, the analytical strategies aforementioned clearly suggest the necessity of
incorporating various types of genetic and functional genomic readouts such that
their inter-relationship might enhance our comprehension of the phenomena under
study. This is more relevant when studying neurodevelopment and their related
diseases as the consequence of multigenetic events. Furthermore, it is important to
mention that data integration is systematically supported by computational devel-
opments, as witnessed by the various tools and computational strategies devoted to
infer relationships among the available data, but also to model systems behavior.
Notably, the use of machine learning strategies for modeling the maturity and
regional identity obtained during neuronal in-vitro assays in comparison with
human fetal brain data, provide means to take advantage of in-vitro systems that
manage to reconstitute as close as possible the in-vivo events [73]. In a similar
manner, major efforts like the “blue brain project” are currently combining data
assessment with computational modeling to reconstruct cell atlas for instance of the
mouse brain [74], strongly suggesting that over the coming years major discoveries
in neuroscience might arise from such multidisciplinary efforts.
4. Perspectives for the coming years: from the use of new in-vitro 3D-
brain tissue models, single cell strategies to big-data systems biology
The majority of transcriptome or related studies in human brain used postmor-
tem tissues as source of material. As consequence, technical concerns like the
potential RNA degradation following pre- and postmortem factors as environment,
collection methods, or postmortem interval could directly influence the quality of
the readouts [75–77]. The use of animal models as an alternative is losing interest
due to the reported differences, for instance in human corticogenesis relative to
mouse models, which are further supported by human specific gene signature and/
or divergences in gene regulatory programs [78–80]. Even if few percentages of
genes have different trajectories in non-human primate and human in contrast to
rodent, this model can help to understand brain development, but it cannot model
all features found in human [79, 81]. In fact, comparison between non-human
Figure 2.
Comparison of 58 nervous system cell/tissue types on the basis of their master TF co-regulatory networks. The
fraction of common TFs pairwise is displayed in percentage (heatmap). The inset displays the identity of the
major TFs retrieved in Frontal cortex compared with those retrieved on hypothalamus. The illustrated data are
extracted from the analysis performed over more than 3000 Affymetrix arrays corresponding to300 cell/tissue
types describing 14 different systems on the human body (Cholley et al. [69]).
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primate and human brains transcriptome analysis showed human specificity in gene
expression profiling [82–84] with demonstration that genes differentially expressed
are principally upregulated in human brains in contrast to other organs [85, 86]. In
addition, the transcriptome remodeling during postnatal periods appears delayed in
human brain comparing to non-human primate [87].
More recently, the use of human-induced pluripotent stem cells (hIPSCs) com-
bined with in-vitro culture strategies for generating two- or three-dimensional
nervous tissue appears as an alternative to animal model systems. In fact, nowadays
it is possible to generate hIPSCs from tissue samples collected from patients
presenting neurological disorders which can be differentiated toward nervous tis-
sue. In this context, a recent study compared the transcriptome of neural stem cells
driven in-vitro toward corticogenesis and discovered a strong conservation with in-
vivo gene expression with the conservation of cortical gene network implicated in
ASD [73]. In contrast to the in-vitro neuronal differentiation in two dimensions, the
generation of three-dimensional models (known as cerebral organoids) appears as a
more relevant physiological model to study neurodevelopment [88–91]. Comparing
human cerebral organoids and fetal brain development demonstrated the similarity
in gene expression programs and epigenomic signatures [92–94]. Furthermore,
single-cell transcriptome analysis over cerebral organoids revealed an important
cellular heterogeneity, reminiscent to what is observed in the human brain [95]. As
a consequence, the use of human cerebral organoids corresponds to a new approach
for modeling the neuronal development and providing means to study neurogenesis
from a systems biology perspective. For example, Mariani et al. generated cerebral
organoids from hIPSCs derived from patients with ASD and recapitulated tran-
scriptional programs present in fetal cortical development. In this study, the use of
gene network analyses allowed to identify upregulated gene programs implicated in
cell proliferation, neuronal differentiation and synaptic process [90]. Similarly,
Amiri et al. identified gene modules implicated in ASD that overlap those described
previously in postmortem data. This study supported the idea that cerebral
organoids provide means to reveal gene regulatory elements contributing to ASD
[94]. Due to these success, major efforts focused on the development of protocols to
generate tissues reminiscent to different brain structures like forebrain [90, 96],
midbrain [96, 97], or hypothalamus [96] were developed. Recently, chimeric
organoids issued from the fusion different regionalized organoids (like dorsal-
ventral forebrain organoids) were generated to increase the complexity of the
generated tissues [98].
The use of cerebral organoids as a model system for studying neurodevelopment
and related diseases is in its infancy. This approach still requires improvements, for
instance in the context of the reproducibility, but due to its alternative to human
postmortem samples and animal models, it is expected to continue to evolve over
the coming years. In fact, this tendency is also boosted by multiple other develop-
ments, including the use of CRISPR/CAS9 system to engineer organoids [99], the
democratization of single cell omics strategies [95], as well as the gain in multidis-
ciplinary approaches, specifically by the incorporation of computational approaches
for modeling brain tissue organization [74].
5. Conclusion
Understanding the brain complexity corresponds to one of the major challenges
for the scientific community. This does not only imply its physiological function,
but also its relationship with the human mind. The use of omics strategies is revo-
lutionizing the way to interpret any living system from the expression of their
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genome, and in the particular case of the human brain, it is enhancing the compre-
hension of neurological disorders. In this chapter, we have discussed the use of
transcriptomes, exome sequencing, and gene regulatory network strategies for
revealing the influence of multiple genes. Furthermore, we have highlighted the
arrival of cerebral organoids as a novel model system for studying human nervous
system, which in combination with further developments (single-cell strategies,
CRISPR-Cas9 engineering, etc.) is a promising major progress for understanding
the brain function. This enthusiasm is further supported with the major advance-
ments in computational developments, notably the artificial intelligence, which
together with the major amounts of data (issued from omics strategies) is expected
to accelerate discoveries. Overall, we expect that this chapter will open the mind to
young readers to further explore the multidisciplinary approaches described herein
to directly participate in the exploration of the human brain in the following years.
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Nomenclature
DNA deoxyribonucleic acid
RT-PCR reverse transcription polymerase chain reaction
RNA ribonucleic acid
RNA-Seq RNA sequencing
EdU 5-ethynyl-20-deoxyuridine
ASD autism spectrum disorder
miRNA micro-RNA
lncRNA long non-coding RNA
RMST rhabdomyosarcoma 2-associated transcript
SOX2 sex determining region Y-box 2
GTex genotype tissue expression
ENCODE encyclopedia of DNA elements
PsychENCODE psychiatric encyclopedia of DNA elements
PET positron emission tomography
SNV single nucleotide variants
CNV copy number variants
GWAS genome-wide association studies
ChIP chromatin immunoprecipitation
TF transcription factor
TBR1 T-box, brain 1
Auts2 activator of transcription and developmental
regulator
CHD8 chromodomain helicase DNA binding protein 8
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ARNT2 aryl hydrocarbon receptor nuclear translocator 2
NPAS3 neuronal PAS domain protein 3
hIPSCs human-induced pluripotent stem cells
CRISPR/CAS9 clustered regularly interspaced short palindromic
repeats/CRISPR-associated 9
Transcriptome total of RNA molecules expressed in a cell or a popu-
lation of cells
Exome the part of the genome composed of exons which are
the coding portions of gene
Epigenome multitude of chemical compounds and proteins that
modify and control the expression of genes without
change in DNA sequence
MicroRNA class of small non-coding RNA molecules of about 22
nucleotides in length that function as posttranscrip-
tional regulators of target genes
LncRNA non-coding RNA molecules greater than 200 nucleo-
tides in length
Single nucleotide variants loci with alleles that differ at a single base
Rare copy number
variants
number of copies of a particular gene that varies
between individuals
Genome-wide association
study (GWAS)
approach to associate specific genetic variations with
particular diseases
Chromatin
immunoprecipitation
procedure to investigate interaction between pro-
teins and genomic DNA regions
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